These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38047832)

  • 1. Quinacrine - The Winding Road from the Most Important Antimalarial of Its Time to an Indispensable Antiparasitic (Orphan) Drug of our Days.
    Neumayr A; Kuenzli E
    Chimia (Aarau); 2023 Sep; 77(9):574-576. PubMed ID: 38047832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Quinacrine in Nitroimidazole-resistant Giardia Duodenalis: An Old Drug for an Emerging Problem.
    Requena-Méndez A; Goñi P; Rubio E; Pou D; Fumadó V; Lóbez S; Aldasoro E; Cabezos J; Valls ME; Treviño B; Martínez Montseny AF; Clavel A; Gascon J; Muñoz J
    J Infect Dis; 2017 Mar; 215(6):946-953. PubMed ID: 28453841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
    Bourque DL; Neumayr A; Libman M; Chen LH
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
    Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
    Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of giardiasis after nonresponse to nitroimidazole.
    Meltzer E; Lachish T; Schwartz E
    Emerg Infect Dis; 2014 Oct; 20(10):1742-4. PubMed ID: 25271363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
    Nabarro LE; Lever RA; Armstrong M; Chiodini PL
    Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis.
    Ydsten KA; Hellgren U; Asgeirsson H
    J Infect Dis; 2022 May; 225(10):1773-1776. PubMed ID: 34036328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
    Carter ER; Nabarro LE; Hedley L; Chiodini PL
    Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giardiasis treatment: an update with a focus on refractory disease.
    Mørch K; Hanevik K
    Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations upon the effects of mepacrine and other substances on Giardia intestinalis.
    THOMAS ME
    Parasitology; 1953 Jan; 42(3-4):262-8. PubMed ID: 13026282
    [No Abstract]   [Full Text] [Related]  

  • 13. Repurposing Quinacrine against Ebola Virus Infection
    Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity.
    Gomes A; Pérez B; Albuquerque I; Machado M; Prudêncio M; Nogueira F; Teixeira C; Gomes P
    ChemMedChem; 2014 Feb; 9(2):305-10. PubMed ID: 24474655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties.
    Chumanevich AA; Witalison EE; Chaparala A; Chumanevich A; Nagarkatti P; Nagarkatti M; Hofseth LJ
    Oncotarget; 2016 Aug; 7(33):52928-52939. PubMed ID: 27447967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
    von Schmiedeberg S; Rönnau AC; Schuppe HC; Specker C; Ruzicka T; Lehmann P
    Hautarzt; 2000 Feb; 51(2):82-5. PubMed ID: 10743578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapeutic treatment of lambliasis. Efficacity of the combination of mepacrine and rodoprequine].
    GONDARD L
    Thorax; 1959; 14():913-9. PubMed ID: 13850942
    [No Abstract]   [Full Text] [Related]  

  • 19. Repurposing quinacrine for treatment-refractory cancer.
    Oien DB; Pathoulas CL; Ray U; Thirusangu P; Kalogera E; Shridhar V
    Semin Cancer Biol; 2021 Jan; 68():21-30. PubMed ID: 31562955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the responses of clones of Giardia intestinalis to anti-giardial drugs.
    Boreham PF; Phillips RE; Shepherd RW
    Trans R Soc Trop Med Hyg; 1987; 81(3):406-7. PubMed ID: 3686635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.